DTU professor to strengthen global effort against global health challenge
Professor Henrik Caspar Wegener has been appointed as Denmark's first high-level representative for antimicrobial resistance. In his new role, he will help strengthen Denmark's efforts and international collaboration against one of the greatest global health threats.
Henrik Wegener. Photo: Universität Heidelberg.
Monday 28 September 2026
Tore Vind Jensen
Professor and Program Director at the National Food Institute (DTU), Henrik Caspar Wegener, has been appointed by Minister for Health Ida Auken as Denmark's new high-level representative for antimicrobial resistance (AMR, see fact box), the Ministry of Health and Ecclesiastical Affairs writes in a press release (in Danish).
"Henrik Wegener is among the country's most experienced researchers and leaders in the field. The appointment is a recognition of the strong research and international impact he has contributed for many years in the fight against antibiotic resistance. It is also an example of how university knowledge can be translated into concrete societal value and help shape solutions to global challenges," says Provost Christine Nellemann.
As a high-level representative, Henrik Caspar Wegener will represent Denmark in international forums until the end of 2028, strengthen collaboration with decision-makers and professional communities worldwide, and help promote Danish solutions in the field. Thus, the role will strengthen international efforts against antibiotic resistance and bring Danish research-based solutions to the world.
Part of the task will therefore be to support the work of the International Center for Antimicrobial Resistance Solutions (ICARS), a Danish-initiated international center based in Copenhagen. ICARS helps low- and middle-income countries translate research and knowledge into concrete solutions that can curb the development of antimicrobial resistance and strengthen healthcare systems' capacity.
"Antimicrobial resistance is one of the greatest health challenges of our time. The challenge is global, and therefore the solutions require close collaboration between researchers, authorities, healthcare systems, and international organizations. Denmark is in a strong position with research, innovation, and practical experience in the field, and I look forward to contributing to bringing that knowledge even more into play internationally,” says Henrik Caspar Wegener.
Fact box
What is antimicrobial resistance?
Antimicrobial resistance (AMR) occurs when microorganisms such as bacteria, viruses, fungi, and parasites develop resistance to the drugs used to fight them.
The most widespread form is antibiotic resistance, where bacteria become resistant to antibiotics. This can make infections harder to treat and increase the risk of severe illness. Antibiotic resistance is considered one of the greatest challenges for modern healthcare because effective treatment of infections is a prerequisite for surgeries, cancer treatment, and intensive care.
